X0202 SCHEDULE 13G 0002046077 XXXXXXXX LIVE Common Stock 03/31/2026 0001826667 TriSalus Life Sciences, Inc. 89680M101 6272 W. 91st Ave. Westminster CO 80031 Rule 13d-1(b) Utmost Group PLC b X0 3503385.00 0.00 3503385.00 0.00 3503385.00 N 5.71 IC HC FI On 31 March 2026, Utmost Group PLC held 3,503,385 units of TriSalus Life Sciences's common shares, representing 5.71% of the outstanding shares. Compared to 30 September 2025, the ownership of Utmost Group PLC in the company decreased by more than 1% as a result of an increase in outstanding shares of the company. TriSalus Life Sciences, Inc. 6272 W. 91st Ave. Westminster, CO 80031 Utmost Group PLC Saddlers' House 5th Floor, 44 Gutter Lane, London, United Kingdom, EC2V 6BR United Kingdom N IC HC FI Insurance Company 3,503,385 shares 5.71% 3,503,385 None 3,503,385 None Y Y N Utmost Luxembourg S.A. - 4, rue Lou Hemmer, L1748 Luxembourg, Luxembourg (Registration number: B37604) Y Y N By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to (J) A non-U.S. institution that is the functional equivalent of any of the institutions listed in ??240.13d 1 (b)(1)(ii)(A) through (I), so long as the non-U.S. institution is subject to a regulatory scheme that is substantially comparable to the regulatory scheme applicable to the equivalent U.S. institutio is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D. Utmost Group PLC /s/ Ian Maidens 05/05/2026